Skip to main content
Britannia Life Sciences logo

Britannia Life Sciences — Investor Relations & Filings

Ticker · BLAB ISIN · CA11042D1087 LEI · 549300PN0TMPKNE2R614 CSE Professional, scientific and technical activities
Open in API
Filings indexed 128 across all filing types
Latest filing 2025-03-03 Interim / Quarterly Rep…
Country CA Canada
Listing CSE BLAB

About Britannia Life Sciences

https://britannia.life/

Britannia Life Sciences operates as a global, vertically diversified product development platform, offering an integrated suite of services that function as a "one-stop-shop" across the entire product lifecycle, from concept to consumer. The company specializes in quality assurance, safety assessment, regulatory compliance, and comprehensive product testing. Core services are delivered through an ISO 17025 accredited laboratory, supporting businesses in the cosmetics, consumer packaged and household goods, nutraceutical, food, and general wellness sectors. The platform includes specialized divisions such as Britannia Labs, which serves the global cannabis industry, and Proof Wellness, an online marketplace for CBD consumers. The company focuses on leveraging its expertise to support clients primarily targeting the UK and European markets.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive set of 'Condensed Interim Consolidated Financial Statements' for Britannia Life Sciences Inc. for the period ending December 31, 2024. It includes the Statement of Financial Position, Statement of Income and Comprehensive Income, Statement of Changes in Shareholders' Equity, Statement of Cash Flows, and detailed notes to the financial statements. It contains substantive financial data and analysis, meeting the criteria for an Interim/Quarterly Report (IR). 9M 2025
2025-03-03 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a press release providing a corporate update on the sale of a subsidiary, net proceeds, strategic capital allocation plans (including share buybacks/dividends), and balance sheet deployment. It is not an earnings release (no financial results for a period), not an M&A transaction notice alone (though sale is an M&A, but it's framed as a corporate update on financing proceeds), and not a report publication announcement. It focuses on capital/financing activities and structure changes, matching the “Capital/Financing Update” category (CAP).
2025-01-28 English
News release - English.pdf
M&A Activity Classification · 1% confidence The document is a corporate press release announcing the strategic sale (divestiture) of the company’s UK operating subsidiary (ADSL), with details on transaction value, consideration structure, use of proceeds, and advisors. This fits squarely within announcements related to merger, acquisition, divestiture, or takeover activity. Therefore, it is classified as M&A Activity (Code: TAR).
2025-01-09 English
Report of exempt distribution (45-106F1).pdf
Capital/Financing Update Classification · 1% confidence The document is a filled-out Form 45-106F1 – a Canadian regulatory report of an exempt distribution of securities, detailing the terms, purchasers, exemptions relied on, and compensation paid in connection with a financing transaction. This is not an AGM or annual report, nor a proxy or dividend declaration, but clearly relates to a fundraising/capital raising activity. Therefore it falls under “Capital/Financing Update” (CAP).
2024-12-02 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a statutory certification (Form 52-109FV2) for interim filings under Canadian NI 52-109. It is not the interim financial report or MD&A itself, nor an announcement that a report is available. Instead, it is a regulatory compliance certificate. None of the specific categories (e.g., IR, RPA) precisely match a certification form, so it fits best under the fallback “Regulatory Filings” category.
2024-11-29 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a NI 52-109 Venture Issuer Basic Certificate certifying the issuer’s interim financial report and MD&A for the quarter ended September 30, 2024. It is not the interim financial report itself (IR), nor an audit opinion (AR), MD&A narrative (MDA), or any other primary report; rather it is a regulatory certification form required by Canadian securities rules. It does not announce the publication of a report (RPA) but is part of regulatory filing documentation. This best fits the fallback Regulatory Filings category.
2024-11-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.